Investigation Overview
October 20, 2015 (Shareholders Foundation) - An investigation on behalf of investors of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares over potential securities laws violations by Valeant Pharmaceuticals Intl and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of p...
You must register (for free) or login to view the entire investigation.